| 英文名称 |
中文名称 |
CAS号 |
操作 |
| GlyH-101 |
GLYH 101 |
328541-79-3 |
详细
|
| Icotinib |
埃克替尼 |
610798-31-7 |
详细
|
| AG 1406 |
AG1406;AG-1406 |
71308-34-4 |
详细
|
| Oglufanide |
H-GLU-TRP-OH |
38101-59-6 |
详细
|
| CNX-2006 |
CNX2006 |
1375465-09-0 |
详细
|
| Cediranib dihydrochloride |
西地尼布 |
288383-20-0 |
详细
|
| AZD9291DA |
AZD9291中间体1 |
1421372-66-8 |
详细
|
| Mutant EGFR inhibitor |
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺 |
1421373-62-7 |
详细
|
| Mubritinib |
木利替尼 |
366017-09-6 |
详细
|
| Regorafenib Hydrochloride |
瑞格非尼盐酸盐 |
835621-07-3 |
详细
|
| Rostafuroxin |
ROSTAFUROXIN |
156722-18-8 |
详细
|
| Semaxanib |
SU5416 |
204005-46-9 |
详细
|
| SU 5205 |
SU 5205; SU-5205; SU5205 |
3476-86-6 |
详细
|
| JK-P3 |
3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺 |
942655-44-9 |
详细
|
| KNK437 |
KNK437 |
218924-25-5 |
详细
|
| SU5408 |
VEGFR2 KISE INHIBITOR I |
15966-93-5 |
详细
|
| Fruquintinib |
呋喹替尼 |
1194506-26-7 |
详细
|
| Brivanib alaninate |
1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2-丙醇 L-丙氨酸酯 |
649735-63-7 |
详细
|
| Tivozanib |
替沃扎尼 |
475108-18-0 |
详细
|
| Lavendustin A |
薰草菌素 |
125697-92-9 |
详细
|
| Afatinib |
阿法替尼 |
439081-18-2 |
详细
|
| Regorafenib monohydrate |
瑞格非尼一水合物 |
1019206-88-2 |
详细
|
| Lusutrombopag |
芦曲泊帕 |
1110766-97-6 |
详细
|
| Vatalanib |
瓦他拉尼碱 |
212141-54-3 |
详细
|
| AC-55541 |
AC-55541 |
916170-19-9 |
详细
|
| Icotinib hydrochloride |
凯美纳 |
1204313-51-8 |
详细
|
| CL-387785 |
CL-387785 |
194423-06-8 |
详细
|
| Brivanib |
酪氨酸激酶抑制剂 |
649735-46-6 |
详细
|
| 3-Methyltoxoflavin |
3-methyl toxoflavin |
32502-62-8 |
详细
|
| Irbinitinib |
妥卡替尼 |
937263-43-9 |
详细
|
| Cediranib maleate |
西地尼布马来酸盐 |
857036-77-2 |
详细
|
| Methyl 2,5-dihydroxycinnamate |
2,5-二羟基肉桂酸甲酯 |
63177-57-1 |
详细
|
| hVEGF-IN-1 |
1637443-98-1 |
1637443-98-1 |
详细
|
| SU 4942 |
SU 4942; SU-4942; SU4942 |
76086-99-2 |
详细
|
| Darusentan |
达卢生坦 |
171714-84-4 |
详细
|
| GSK-3787 |
GSK-3787 |
188591-46-0 |
详细
|
| EAI045 |
EAI-045 |
1942114-09-1 |
详细
|
| AZ5104 |
奥西替尼中间体 |
1421373-98-9 |
详细
|
| AZD-8931 |
AZD8931 |
848942-61-0 |
详细
|
| EGF816 |
EGF816 |
1508250-71-2 |
详细
|
| Zibotentan |
齐泊腾坦 |
186497-07-4 |
详细
|
| AG-1557 |
AG-1557 |
189290-58-2 |
详细
|
| AV-412 |
AV-412 |
451492-95-8 |
详细
|
| Naquotinib |
NAQUOTINIB |
1448232-80-1 |
详细
|
| WZ-4002 |
WZ4002 |
1213269-23-8 |
详细
|
| MSDC-0602 |
1133819-87-0 |
1133819-87-0 |
详细
|
| IOX2 |
IOX 2 |
931398-72-0 |
详细
|
| Lanifibranor |
IVA-337 |
927961-18-0 |
详细
|
| MS023 |
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 |
1831110-54-3 |
详细
|
| EPZ015866 |
GSK591 (EPZ-015866) |
1616391-87-7 |
详细
|
| UNC1215 |
UNC1215 |
1415800-43-9 |
详细
|
| EPZ015666 |
EPZ015666 |
1616391-65-1 |
详细
|
| UNC-0638 |
UNC0638 |
1255580-76-7 |
详细
|
| Pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
详细
|
| MDK34597 |
PIK抑制剂 |
371934-59-7 |
详细
|
| ETP-46321 |
CS-2500 |
1252594-99-2 |
详细
|
| Copanlisib |
库潘尼西 |
1032568-63-0 |
详细
|
| XL147 |
XL147 |
956958-53-5 |
详细
|
| 3-Methyladenine |
6-氨基-3-甲基嘌呤 |
5142-23-4 |
详细
|
| GDC0941 |
GDC-0941 |
957054-30-7 |
详细
|
| PIK 75 hydrochloride |
2-甲基-5-硝基苯磺酸 [(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]甲基肼盐酸盐 |
372196-77-5 |
详细
|
| AZD8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
详细
|
| LY-900009 |
LY900009 |
209984-68-9 |
详细
|
| XL 765 |
XL765 |
1349796-36-6 |
详细
|
| Umbralisib |
TGR-1202 |
1532533-67-7 |
详细
|
| VPS34-IN1 |
VPS34-IN1 |
1383716-33-3 |
详细
|
| AS-604850 |
5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮 |
648449-76-7 |
详细
|
| Rigosertib sodium |
N-[2-甲氧基-5-[[[2-(2,4,6-三甲氧基苯基)乙烯基]磺酰]甲基]苯基]甘氨酸钠盐 |
1225497-78-8 |
详细
|
| Preladenant |
瑞德南特 |
377727-87-2 |
详细
|
| CPI-444 |
CPI-444 |
1202402-40-1 |
详细
|
| HMN-214 |
(E)-4-[2-[2-[N-乙酰基-N-[(4-甲氧基苯基)磺酰]氨基]苯基]乙烯基]吡啶 1-氧化物 |
173529-46-9 |
详细
|
| GSK-461364 |
GSK461364 |
929095-18-1 |
详细
|
| Obatoclax mesylate |
Obatoclax 甲磺酸盐 |
803712-79-0 |
详细
|
| CID5721353 |
301356-95-6 |
301356-95-6 |
详细
|
| Elafibranor |
GFT505 |
923978-27-2 |
详细
|
| GW 627368X |
GW627368X |
439288-66-1 |
详细
|
| Palosuran |
ACT 058362; PALOSURAN, |
540769-28-6 |
详细
|
| 17-Phenyl Trinor Prostaglandin F2α Methyl Amide |
比马前列素甲胺 |
155206-01-2 |
详细
|
| PD123319 |
PD 123319 |
130663-39-7 |
详细
|
| WAY-100635 maleate |
WAY-100635 |
634908-75-1 |
详细
|
| Eltoprazine hydrochloride |
1-(2,3-二氢苯并[B][1,4]二氧杂芑-5-基)哌嗪 |
98206-09-8 |
详细
|
| Cloprostenol sodium |
氯前列烯醇钠 |
55028-72-3 |
详细
|
| E7046 |
E-7046 |
1369489-71-3 |
详细
|
| Asenapine maleate |
阿塞那平马来酸盐 |
85650-56-2 |
详细
|
| Vabicaserin hydrochloride |
VABICASERIN HYDROCHLORIDE |
887258-94-8 |
详细
|
| Lasmiditan hydrochloride |
613677-28-4 |
613677-28-4 |
详细
|
| Naronapride dihydrochloride |
CS-632 |
860169-57-9 |
详细
|
| DSP-6952 hydrobromide |
Minesapride |
1184661-33-3 |
详细
|
| Lasmiditan hemisuccinate |
琥珀酸拉斯米迪坦 |
439239-92-6 |
详细
|
| AVN-492 |
CS-2812 |
1220646-23-0 |
详细
|
| Quinine hemisulfate dihydrate |
硫酸奎宁 |
6119-70-6 |
详细
|
| Tertiapin |
tertiapin |
58694-52-3 |
详细
|
| Almotriptan Malate |
依来曲普坦 |
181183-52-8 |
详细
|
| Lu AE58054 HCl salt |
N-[2-(6-氟-1H-吲哚-3-基)乙基]-3-(2,2,3,3-四氟丙氧基)苄基胺单盐酸盐 |
467458-02-2 |
详细
|
| GS967 |
GS967 |
1262618-39-2 |
详细
|
| Vortioxetine HBr |
氢溴酸沃替西汀 |
960203-27-4 |
详细
|
| SB742457 |
3-苯基磺酰基-8-(哌嗪-1-基)喹啉 |
607742-69-8 |
详细
|
| BMS-779788 |
化合物XL652 |
918348-67-1 |
详细
|
| SB-3CT |
SB-3CT |
292605-14-2 |
详细
|
| GW3965 Hydrochloride |
2-[3-[3-[[2-氯-3-(三氟甲基)苄基](2,2-二苯基乙基)氨基]丙氧基]苯基]乙酸盐酸盐 |
405911-17-3 |
详细
|